Latest Market Strategy News

betr Entertainment has successfully raised $130 million through a fully underwritten equity offer priced at a 13.7% premium, underpinning its strategic acquisition of PointsBet and positioning for growth in the Australian wagering market.

ImpediMed Limited reported a record A$3.4 million revenue in Q3 FY25, bolstered by a surge in Annual Recurring Revenue and a strategic sales leadership change aimed at accelerating SOZO platform adoption.

Beforepay Group Limited has reported its strongest Q3 FY25 performance yet, with net profit before tax tripling year-on-year and advances growing 16%. The fintech’s strategic expansion of Carrington Labs and funding optimisations signal robust momentum ahead.

Woodside Energy has approved the final investment decision for its Louisiana LNG development, a major three-train project targeting first LNG in 2029 with strong returns and emissions targets intact. This move positions Woodside as a global LNG powerhouse with a diversified portfolio and significant cash flow potential.

Mach7 Technologies reported a robust Q3 FY25 with a CARR of A$30.8 million and positive operating cash flow, while announcing a leadership change and reaffirming growth guidance.

Alma Metals has released a significant update to its Briggs Copper JV Project resource, incorporating silver for the first time and demonstrating high copper recoveries. The company is progressing a scoping study and preparing for further drilling to expand and upgrade the resource.

Iluka Resources posted a solid 2024 performance with stable market conditions and sound margins despite inflationary pressures, while progressing key projects like Balranald and Eneabba.

EBOS Group Limited posted robust interim results for H1 FY25, with underlying EBITDA rising 7.1% excluding the Chemist Warehouse Australia contract, driven by strong organic growth and strategic investments. The company maintained its dividend and reiterated FY25 EBITDA guidance between $575 million and $600 million.

Simonds Group reported a 5.6% revenue decline for the half year ended December 2024 but achieved a 12% rise in EBITDA, driven by higher margin projects and cost control. The company also announced a strategic acquisition to expand its footprint.

Memphasys has initiated clinical utility testing of its Felix™ System in Brazil through a partnership with Laboratorio Androscience, aiming to establish a foothold in the rapidly growing Latin American IVF sector.

GWA Group Limited reported a 1.9% revenue increase and a 3.2% rise in normalized EBIT for the half year ended December 2024, alongside a 7.1% lift in its interim dividend, reflecting disciplined execution despite tough market conditions.

Audinate’s 1H25 results surpassed market expectations despite a 29% drop in gross profit, driven by a strategic shift towards higher-margin software products and a robust cash position.